BCM
PMD

Bridgeway Capital Management’s Psychemedics Corporation PMD Stock Holding History

Bridgeway Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,000
Closed -$247K – 1484
2016
Q4 		$247K Buy
+10,000
New +$224K ﹤0.01% 1271

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Bridgeway Capital Management's PMD Position: Q1 2017 in Review

Bridgeway Capital Management sold out of Psychemedics Corporation (PMD) in Q1 2017, closing a stake of 10,000 shares — an estimated $247K sold.

Bridgeway Capital Management first reported a position in PMD in Q4 2016 and held it in 1 quarter. The position peaked at $247K in Q4 2016. 53 funds tracked by Wall St. Rank hold PMD as of Q1 2017.

  • Bridgeway Capital Management reported no remaining Psychemedics Corporation position as of Q1 2017 after selling out during the quarter.
  • Bridgeway Capital Management sold 10,000 Psychemedics Corporation shares in Q1 2017, an estimated $247K.
  • Bridgeway Capital Management first reported a position in Psychemedics Corporation in Q4 2016 and held it in 1 quarter.
  • Bridgeway Capital Management's Psychemedics Corporation position peaked at $247K in Q4 2016.
  • 53 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2017.

Based on Bridgeway Capital Management's 13F filing for Q1 2017, filed 15 May 2017.